Tel.: 514-340-8223
albert.cohen@mcgill.ca

Researcher:
Stefania D’Aleo
Tel: 514-340-8222 ext. 24332
stephanie.daleo.ccomtl@
ssss.gouv.qc.ca
Dr. Albert Cohen
 
Senior Investigator, Lady Davis Institute
Director, Division of Gastroenterology, Department of Medicine, Jewish General Hospital
Head, IBD Clinical Unit, Division of Gastroenterology, Jewish General Hospital
Head, Biliary and Pancreatic Therapeutic Endoscopy, Division of Gastroenterology, Jewish General Hospital
Attending Physician, Division of Gastroenterology, Department of Medicine, Jewish General Hospital & Royal Victoria Hospital
Associate Professor, Faculty of  Medicine, McGill University
 
 
Dr. Albert Cohen graduated from McGill University in 1980, and received his MD from the University of Montreal in 1985. He completed his training in gastroenterology in 1990. He has been on staff at the Jewish General Hospital since 1992, and has been the Director of the Division of Gastroenterology since 2000. He is an Associate Professor of Medicine at McGill University.


Major Research Activities

His research focus is primarily on new therapeutic agents for the treatment of inflammatory bowel diseases (IBD), as well as studying various approaches to the treatment of IBD and its impact on patients.


Recent Publications

Feagan BG, Greenberg GR, Wild G, Fedorak RN, Paré P, McDonald JW, Dubé R, Cohen A, Steinhart AH, Landau S, Aguzzi RA, Fox IH, Vandervoort MK: Treatment of Ulcerative Colitis with a Humanized Antibody to the ∞4 β7 Integrin. N Engl J Med, 353:1180-1, 2005

Alexandra-Chloé Villani, Mathieu Lemire, Geneviè Fortin, Edouard Louis, Mark S Silverberg, Catherine Collette, Nobuyasu Baba, Cécile Libioulle, Jacques Belaiche, Alain Bitton, Daniel Gaudet, Albert Cohen, Diane Langelier, Paul R Fortin, Joan E Wither, Marika Sarfati, Paul Rutgeerts, John D Rioux, Severine Vermeire, Thomas J Hudson, Denis Franchimont. Common Variants in the NLRP3 region contribute to Crohn’s disease susceptibility. Nature Genetics, 2009;41(1): 71-6.

Shugart YY, Silverberg MS, Duerr RH, Taylor KD, Wang MH, Zarfas K, Schumm LP, Bromfield G, Steinhart AH, Griffiths AM, KANE SV, Barmada MM, Rotter JI, Mei L, Bernstein CN, Bayless TM, Langelier D, Cohen A, Bitton A, Rioux JD, Cho JH, Brant SR. An SNP linkage scan identifies significant Crohn’s disease loci on chromosones 13q13.3 and in Jewish families on 1p35.2 and 3q29. Genes Immun 2008;9(2): 161-7.
Snapshot

Director of Gastroenterology, Jewish General Hospital.

Extensive research in novel therapies for IBD.
 
 
Important Links

 
Support research at the Lady Davis Institute - Jewish General Hospital